The Declining Standards of FDA Drug Approvals

Maryanne Demasi

The US Food and Drug Administration (FDA) has a legal obligation to protect the public and ensure that the benefits of medicines outweigh the harms before being marketed to people.

But the agency’s increasing reliance on pharmaceutical industry money has seen the FDA’s evidentiary standards for drug approvals significantly decline.

… Industry fees were meant to speed up drug approvals – and they did. In 1988, only 4% of new drugs introduced onto the global market were approved first by the FDA, but that rose to 66% by 1998 after its funding structure changed.

… Consequently, faster approvals have resulted in new drugs that are more likely to be withdrawn for safety reasons, more likely to carry a subsequent black-box warning, and more likely to have one or more dosages voluntarily discontinued by the manufacturer.

Latest articles

Bruce Scott In Part I of Menticide 101 and the Brainwashing of...
Bruce Scott It has become quite clear, especially during the last two...
Joseph Mercola Scientists warn repeated COVID boosters may result in lowered immunity...
Mitchell Brent Liester Chlorine dioxide has been condemned as a dangerous poison...
Paul Elkins The recent White House guidance for people to take the...
Igor Chudov The times are changing! Remember how we said that vaccine shedding...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!